These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 31279292

  • 1. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
    Fedorowicz J, Sączewski J, Konopacka A, Waleron K, Lejnowski D, Ciura K, Tomašič T, Skok Ž, Savijoki K, Morawska M, Gilbert-Girard S, Fallarero A.
    Eur J Med Chem; 2019 Oct 01; 179():576-590. PubMed ID: 31279292
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.
    Hubschwerlen C, Specklin JL, Sigwalt C, Schroeder S, Locher HH.
    Bioorg Med Chem; 2003 May 15; 11(10):2313-9. PubMed ID: 12713843
    [Abstract] [Full Text] [Related]

  • 3. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.
    Eur J Med Chem; 2022 Jan 15; 228():114021. PubMed ID: 34871841
    [Abstract] [Full Text] [Related]

  • 4. Novel oxazolidinone-quinolone hybrid antimicrobials.
    Gordeev MF, Hackbarth C, Barbachyn MR, Banitt LS, Gage JR, Luehr GW, Gomez M, Trias J, Morin SE, Zurenko GE, Parker CN, Evans JM, White RJ, Patel DV.
    Bioorg Med Chem Lett; 2003 Dec 01; 13(23):4213-6. PubMed ID: 14623004
    [Abstract] [Full Text] [Related]

  • 5. Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism.
    Cui SF, Addla D, Zhou CH.
    J Med Chem; 2016 May 26; 59(10):4488-510. PubMed ID: 27115717
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M, Salarinejad S, Güran M, Şanlıtürk G, Emamgholipour Z, Bijanzadeh HR, Toolabi M, Foroumadi A.
    Daru; 2020 Dec 26; 28(2):661-672. PubMed ID: 33030668
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
    Hofny HA, Mohamed MFA, Gomaa HAM, Abdel-Aziz SA, Youssif BGM, El-Koussi NA, Aboraia AS.
    Bioorg Chem; 2021 Jul 26; 112():104920. PubMed ID: 33910078
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
    Hubschwerlen C, Specklin JL, Baeschlin DK, Borer Y, Haefeli S, Sigwalt C, Schroeder S, Locher HH.
    Bioorg Med Chem Lett; 2003 Dec 01; 13(23):4229-33. PubMed ID: 14623007
    [Abstract] [Full Text] [Related]

  • 9. Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.
    Panda SS, Liaqat S, Girgis AS, Samir A, Hall CD, Katritzky AR.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3816-21. PubMed ID: 26253630
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
    Foroumadi A, Firoozpour L, Emami S, Mansouri S, Ebrahimabadi AH, Asadipour A, Amini M, Saeid-Adeli N, Shafiee A.
    Arch Pharm Res; 2007 Feb 15; 30(2):138-45. PubMed ID: 17366732
    [Abstract] [Full Text] [Related]

  • 11. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS, Almalki AJ, Moustafa AH, Allam RM, Abuo-Rahma GEA, El Subbagh HI, Mohamed MFA.
    Bioorg Chem; 2021 Jun 15; 111():104885. PubMed ID: 33838559
    [Abstract] [Full Text] [Related]

  • 12. Piperazine-azole-fluoroquinolone hybrids: Conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies.
    Mermer A, Faiz O, Demirbas A, Demirbas N, Alagumuthu M, Arumugam S.
    Bioorg Chem; 2019 Apr 15; 85():308-318. PubMed ID: 30654222
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
    El-Shershaby MH, El-Gamal KM, Bayoumi AH, El-Adl K, Ahmed HEA, Abulkhair HS.
    Arch Pharm (Weinheim); 2021 Feb 15; 354(2):e2000277. PubMed ID: 33078877
    [Abstract] [Full Text] [Related]

  • 14. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
    Salem MA, Ragab A, Askar AA, El-Khalafawy A, Makhlouf AH.
    Eur J Med Chem; 2020 Feb 15; 188():111977. PubMed ID: 31927313
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
    Hashem HE, Amr AEE, Nossier ES, Elsayed EA, Azmy EM.
    Molecules; 2020 Jun 15; 25(12):. PubMed ID: 32549386
    [Abstract] [Full Text] [Related]

  • 16. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
    Cheng J, Thanassi JA, Thoma CL, Bradbury BJ, Deshpande M, Pucci MJ.
    Antimicrob Agents Chemother; 2007 Jul 15; 51(7):2445-53. PubMed ID: 17502409
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V, Belakhov V, Hainrichson M, Yaron S, Baasov T.
    J Med Chem; 2009 Apr 23; 52(8):2243-54. PubMed ID: 19301822
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M, Tammela P, Barančoková M, Tomašič T, Ilaš J, Kikelj D, Zidar N.
    ChemMedChem; 2018 Jan 22; 13(2):186-198. PubMed ID: 29206345
    [Abstract] [Full Text] [Related]

  • 19. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM, Zamami Y, Kandahary RK, Tsuchiya T, Ogawa W, Iwado A, Sasaki K.
    J Med Chem; 2011 Jun 09; 54(11):3686-703. PubMed ID: 21534606
    [Abstract] [Full Text] [Related]

  • 20. A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV.
    Wang LL, Battini N, Bheemanaboina RRY, Ansari MF, Chen JP, Xie YP, Cai GX, Zhang SL, Zhou CH.
    Eur J Med Chem; 2019 Oct 01; 179():166-181. PubMed ID: 31254919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.